9:30 – 10:00

Inaugural of International Exhibition

10:00 - 11:00

Inaugural Ceremony

Shri. Anumula Revanth Reddy, Hon’ble Chief Minister of Telangana
Shri. Duddilla Sridhar Babu, Hon’ble Minister for Industries and Commerce, Government of Telangana
Her Excellency the Honourable Dr Jeannette Young AC PSM, Governor of Queensland, Australia

11:00 - 11:20

Keynote Address by Mr. Robert A. Bradway, CEO, Amgen

11:20 - 11:40

Keynote Address by Prof. Patrick Tan, Executive Director of PRECISE Singapore, Senior Vice Dean (Research) at Duke-NUS Medical School, and Chief Scientific Officer at the Genome Institute of Singapore- Genome Valley Excellence Awardee

11:40 - 12:55

Panel Discussion - AI Transformation in Healthcare

Conversation to centre around application of AI across the entire pharma value chain viz R&D, Supply Chain, Operations, Quality, Manufacturing, and Commercialization – both regular Pharmaceuticals and CRDMOs. We will also discuss the future direction for AI integration in healthcare, including vital considerations around cybersecurity, data privacy, and continuous adoption.

Speakers:

Dr. Ken Washington, CTO, Medtronic, USA – Opening Plenary
Dr. Nageshwar Reddy, Chairman and Founder, Asian Institute of Gastroenterology (AIG), India
Dr. Shyam Bishen, Head, Centre for Health and Healthcare; Member of the Executive Committee, World Economic Forum, Switzerland
Dr. Olga Kubassova, President, Image Analysis Group (IAG), UK
Dr. Ricardo Gaminha Pacheco, Director, Insilico Medicine, Switzerland
Moderator: Chaitanya Royyuru, Partner, EY, UK

Session Sponsor:

12:55 - 14:00

Networking Lunch & Visit to Exhibition

14:00 - 15:15

Panel Discussion - Unleashing the tiger: Indian CRDMO sector

Session Brief: India’s CRDMO market, currently valued at ~$4 billion, is set for rapid growth, driven by China+1 shifts, pricing pressures from the IRA, advancements in new modalities, and a growing focus on local innovation. However, to fully capitalize on this opportunity, the industry must address key challenges—including scaling talent, building a Tier 1 supplier ecosystem, unlocking access to capital, strengthening sustainability measures, and enabling sector-friendly policies and regulations. Success will require stakeholders across the ecosystem (e.g., CRDMO companies, government, Tier 1 suppliers, and global customers) to drive concrete progress. This panel will explore the industry’s potential, barriers, and the critical enablers needed to position India as a global CRDMO powerhouse.

Speakers:

Peter Bains, CEO Designate, Syngene, India
Manni Kantipudi, CEO, Aragen Lifesciences, India
Krishna Kanumuri, Managing Director & CEO, Sai Lifesciences, India
Nandini Piramal, Chairperson, Piramal Pharma Ltd, India
Ramesh Subramaniam, CEO, PI Health Sciences, India
Guilano Perfetti, Managing Director & CEO, Jubilant Biosys, Italy
Akhil Ravi, CEO, Aurigene Pharmaceutical Services, India
Moderator: Mr. Vikash Agarwalla, MD & Partner, BCG, India

Session Sponsor:

15:15 – 15:30

Keynote Address by Mr. Amitabh Kant IAS, India’sG20 Sherpa, Government of India

15:30 – 16:40

Panel Discussion – Innovations shaping the future of the Global Life Sciences landscape

Life sciences companies face critical pricing and access issues, with significant revenue at risk from expiring patents, which is pushing them to focus on improving the productivity of their R&D functions through innovations, among other strategies. This panel seeks to explore how innovations like Lab of the Future, AI-driven drug discovery, Digital twins, decentralized and in-silico clinical trials, IOT etc. are redefining the global R&D, Manufacturing, and Supply Chain landscape, driving personalized medicine, and positioning the life sciences sector at the forefront of innovation.

Speakers:

Dr. Shekar Mande, Former Director General, CSIR, India
Dr. Boris Stoffel, Managing Director, Miltenyi Biotec, Germany
Christian Jones, Chief Commercial Officer, Nanoform, Finland
Nitin Dharmadhikari, Chief Operating Officer, SPARC, India
Sandhya Sreepathy, Novartis Biomedical Research Head, India
Dr. Anil Koul, Vice President & Head, Global Public Health Discovery, Johnson & Johnson, Belgium

Moderator: Peter Lyons, Vice Chair and US National Life Sciences Leader, Deloitte

Moderated by:

Session Sponsor:

16:40 - 17:40

Panel Discussion – Strengthening the Global Bioeconomy and Transforming Human Health Through Generative Biology (In Collaboration with World Economic Forum(WEF))

Biotechnology stands at a critical juncture, driven by rapid technological progress and shifting global dynamics in healthcare and life sciences. While breakthroughs like generative biology and biomanufacturing have the potential to transform the sector, challenges such as resource limitations, knowledge gaps, and structural disincentives persist. In parallel, Asia—and India in particular—are emerging as leaders in shaping the global biotech landscape, leveraging expertise in manufacturing and healthcare innovation. This session will discuss how the healthcare ecosystem can address barriers, capitalize on opportunities, and position biotechnology as a cornerstone of transformative healthcare solutions.

Speakers:

Dr. Toon Overstijns, CEO, Miltenyi Biomedicine, Germany
Dr. Marinna Madrid, Co-Founder & Chief Product Officer, Cellino Biotech, USA
Dr. K. Anand Kumar, Managing Director, Indian Immunologicals Limited, India
Sanjiv Navangul, Managing Director and CEO, Bharat Serums and Vaccines Ltd, India
Prof Ullas S Kolthur, Director, Centre for DNA Fingerprinting and Diagnostics, India
Sai Prasad, Executive Director, Bharat Biotech International Ltd, India
Moderator: Brynne Stanton, Bioeconomy Lead, World Economic Forum

Session Sponsors:

18:00 - 19:30

CEO Conclave - India's Century: Leading the Global Innovation Charge in Life Sciences

Speakers:

Dr. S. Somanath, Former Chairman, ISRO, India
G.V. Prasad, Co-Chairman & Managing Director Dr. Reddy's Laboratories, India
Dr. Satyanarayana Chava, Founder and Chief Executive Officer, Laurus Labs, India
Cesar Concepcion, Chief Commercial Officer,APMA region, Novartis, Singapore
Winselow Tucker, President and General Manager, Lilly India, USA
Moderator: Govindraj Ethiraj, Founder and Editor, TheCore.in

CEO Conclave Sponsor:

19:30 Onwards

Networking Reception

10:30 – 10:45

Visit to Exhibition and Start-Ups

10:45 – 11:00

Plenary Address by Dr. David Reese, Executive Vice President & Chief Technology Officer, Amgen

11:00 – 11:15

Plenary Address by Mr. Dave Williams, Executive Vice President, Chief Information and Digital Officer, MSD

11:15 – 12:15

Panel Discussion - Life Sciences GCCs - From Cost Arbitrage to Value Arbitrage

Global Capability Centers (GCCs) in India have evolved from cost-effective operational hubs to strategic drivers of global transformation. No longer just back-office support, they are now at the forefront of accelerating clinical research through advanced analytics, AI-driven insights, and world-class R&D capabilities. Leveraging India’s deep talent pool, GCCs are fostering breakthrough innovations in life sciences and healthcare while also aligning with global ESG priorities by integrating sustainability and governance into their operations. Additionally, they are strengthening resilience and efficiency in global supply chains by harnessing India’s expertise and digital capabilities. This session will explore how GCCs are redefining their role, moving beyond cost efficiency to become centers of excellence, innovation, and strategic value.

Speakers:

John Dawber, Corporate Vice President & Managing Director – Global Business Services, Novo Nordisk
Siva Kumar Padmanabhan, MD & Head of Global Innovation Technology Center, AstraZeneca India
Mohit Dhingra, Managing Director and Head of Business Insights & Technology, Hyderabad, Bristol Myers Squibb
Phani Mitra B, Global CIO & CDO, Dr. Reddy’s Laboratories
Puneet Chopra, Head of Data, Digital and Technology (DD&T), Takeda
Rajiv Onat, India Head, Digital Technology and Engineering, Regeneron
Moderator: Dr. Purav Gandhi, Co-Founder &CEO, HealthArk

Session Sponsor:

12:15 – 13:15

Panel Discussion – Navigating the Transformative Forces Reshaping the Future of Health:

The future of health is being dynamically reshaped by a confluence of transformative forces. These include technological advancements, such as artificial intelligence and data interoperability, which are revolutionizing patient care and operational efficiencies. Additionally, demographic shifts, including aging populations and the rise of chronic diseases, are altering healthcare demands and delivery models. Economic pressures and regulatory changes are also driving innovation and necessitating new business models. This panel discussion will delve into these critical forces, highlighting the imperative for life sciences and healthcare stakeholders to adapt and thrive in a rapidly evolving landscape.

Speakers:

Raj Gore, Chief Executive Officer, HCG (Healthcare Global Enterprises Ltd)
Dr. Rajendra Pratap Gupta, President, Global Digital Health Corporation
Dr. IlankumaranKaliamoorthy, CEO, Rela Hospital
Dr Hari Prasad, Group Chairman and Non-Executive Director, CARE Hospitals
Alex Koehler, Vice President, Head of Digital, Technology and Innovation, Amgen
Moderator: Jerry Bruno - US National Health Care Consulting Leader, Deloitte

Moderated by:

Session Sponsor:

13:15 – 14:15

Networking Lunch & Visit to Exhibition

14:15 – 15:25

Panel Discussions – Clinical Trials - India's great opportunity and how to capture the market

With clinical trials facing delays and geopolitical shifts disrupting traditional hubs like Russia, Ukraine, and China, India emerges as a promising destination for global trials. Factors such as a growing number of GCCs, large patient population, ability to improve access to medicines. This session delves into India's readiness to seize this opportunity, the key challenges to overcome from a hospital / provider perspective, and how India can position itself as a global leader in efficient, scalable, and high-quality clinical trials.

Speakers:

Evelin Tiralongo, Director, Clinical Trial Unit, Griffith University, Australia
Sadhna Joglekar, Sr. VP and Head – Novartis Development India, India
Yves Dethier, Founder, Boostcode, Professor in Statistical Analysis and Supply Chain, EPHEC, Belgium
Sanjay Vyas, President, Global Head – Safety Services & Clinical Logistics | Managing Director – India, Parexel International
Lisa Nelson, CEO, Scientia Clinical Research Limited, Australia
Dr. Taruna Madan Gupta, Head Development Research, Indian Council of Medical Research, India
Dr. Padmaja Lokireddy, Oncologist, Apollo Hospitals, India
Smruthi Suryaprakash, Partner, BCG, India
Moderator: Vikas Dandekar, Editor Pharma and Healthcare, ET Prime

Session Sponsor:

15:25 – 16:25

Panel Discussions – Integrated Healthcare & Patient Outcomes

Focusing on the development of integrated and holistic care models, orchestrated by an ecosystem of the role of technology in improving healthcare access and delivery, the importance of public-private partnerships, and innovative insurance and financing models that can shape the future of healthcare.

Speakers:

Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech International Ltd, India
Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals, India
Dr. Samantha Atkinson, Executive Vice President, NSF Health Sciences & Former Chief Quality & Access Officer, MHRA, UK
Cdr. Divya Prakash Joshi, Vice President Engineering & Board Member MEIC, Global Technology & Innovation, Medtronic, USA
Rajiv Nath, MD, Hindustan Syringes & Medical Devices Ltd & Forum Coordinator AIMED, India
Ajay Mahipal, Managing Director and Partner, HealthQuad

Moderator: Suresh Subramanian, Partner, EY

Session Sponsor:

16:25 – 16:45

Keynote Address by Shri Piyush Goel, Hon’ble Union Minister for Commerce and Industry, Government of India

16:45 – 17:30

Valedictory and Startup Awards Ceremony

Chief Guest: Shri G. Kishan Reddy, Hon’ble Union Minister for Coals and Mines, Government of India
Guests of Honor: Shri Mallu Bhatti Vikramarka, Hon’ble Deputy Chief Minister, Government of Telangana
Shri Duddilla Sridhar Babu, Hon’ble Minister for Industries and Commerce, Government of Telangana